Mark Warner went on CNN this week to call Trump's trade war "his biggest folly," a line that landed well on Bluesky and got the usual round of approving nods from the resistance-posting class. Which is fine. He's not wrong about tariffs. But while Warner was crafting his soundbite for the cable-news archive, his disclosure filings show he was also moving money. Thirty trades in 90 days. Buys in Wells Fargo, Microsoft, Blackstone, and Rocket Companies. Sales out of ETFs and Amgen. The senator sits on the Banking Committee, the Finance Committee, and the Senate Select Committee on Intelligence. His portfolio is, to put it gently, not idle.
The Quote and the Calendar
Warner told CNN he believes the tariff policy will be remembered as Trump's worst mistake. That's a strong call from a guy who's been in the Senate long enough to have witnessed several contenders for that title. On Bluesky, his Intel Committee positioning on FISA 702 and the DNI pick has generated its own thread economy. The progressive corner of the internet is, as ever, unsure whether to praise him or put him on the Lieberman-Manchin-Sinema cautionary list.
He can hold both reputations simultaneously. The filings don't care about the discourse.
April 13: The Day the Portfolio Got Busy
Per the disclosure record on Blind Trust, April 13 was a productive Sunday for someone in the Warner household. Eleven transactions filed on a single date: sales out of three ETFs (ETFIWF, ETFIWD, ETFVUG) and purchases of Wells Fargo, Microsoft, Blackstone, Rocket Companies, and several other positions. Each in the $1,000-$15,000 range, which is the disclosure band that tells you the trade happened without telling you much about the size.
That's the rule. Members must disclose within 45 days. They are not required to divest, recuse, abstain, or explain the timing. The system was designed with exactly this amount of accountability baked in.
Warner also bought Hershey on April 8, picked up an ETFIWF position the same day, and sold Amgen on both April 6 and April 7. Two Amgen sales on consecutive days. That's a pattern, not a pocket change rebalance.
The Committee Overlap Problem (His, Specifically)
Warner's committee assignments are the relevant frame here. He sits on Banking, Housing, and Urban Affairs, including its subcommittees on Financial Institutions, Digital Assets, and Securities. He's on Finance. He's the Vice Chair of the Select Committee on Intelligence.
That's a wide jurisdiction. It touches banks. It touches tech. It touches biotech through Finance's health care subcommittee.
Per the scored trades in the disclosure record, five positions carry a committee overlap flag. Three buys: Fifth Third Bancorp purchased March 20 (Banking overlap, +7.8% 30-day alpha vs. The S&P 500), Microsoft purchased April 13 (Technology overlap, +6.3%), and Apple purchased March 20 (Technology overlap, +2.8%). Then Wells Fargo, also purchased April 13, Banking overlap, -8.7%. And the Amgen sales: the April 7 sale logged -12.9% alpha, the April 6 sale -14.4%. Both flagged under Biotechnology overlap.
To be precise about what that means: those Amgen sales lost ground relative to the index. Warner sold, and Amgen kept going up. It's the profile of someone who sold at the wrong moment, twice, in a sector adjacent to his committee work.
The Actual Alpha Record
The full scored sample is 13 trades. Five ended positive against the S&P 500. Eight finished negative. Mean 30-day alpha: -3.8%.
That's the number. Not a winning streak, not a record that demands an explanation. Just a man who trades more than most senators and is, by the math, slightly underperforming the index he's theoretically ahead of.
The best individual trade in the window: Rocket Companies, purchased April 13, +8.5% alpha in 30 days. No committee overlap flagged. The worst: that LNG sale on March 20, which printed -20.1% against the index. Also no committee overlap. The trades that look worst relative to the market are the ones that don't carry a jurisdictional flag. The ones that do carry overlap flags produced a mixed bag.
The receipts are public. Make of them what you make of them.
The Votes He's Been Casting
Floor votes are not the same as committee oversight, and we won't pretend otherwise. But the roll-call record in the same window is worth noting alongside the portfolio moves.
On May 13, Warner voted Yea on three separate motions to proceed on resolutions disapproving CFPB rule withdrawals: one on medical debt collection, one on overdraft opt-in practices, one on servicemember examination protections. All three motions failed. The banking and consumer finance overlap with his committee assignments is direct. Wells Fargo, purchased April 13, sits squarely in that jurisdiction. The purchase predates the votes by a month, and the votes lost. The timing doesn't line up into a clean story. It also doesn't not line up.
On June 3 he voted to proceed on a resolution disapproving an EPA rollback of emissions standards for coal and oil plants. Voted no on the Fallen Servicemembers Religious Heritage Restoration Act on June 5. Voted yes on the motion to discharge the Iran war powers resolution in May.
None of those floor votes connect to the April 13 trading cluster in a way the data can support. A floor vote on an Iran war powers resolution is a floor vote, not a Banking subcommittee action. Warner votes on a lot of things. So does everyone in the chamber. The committee overlap is the story; the floor record is just context.
The Broader Pattern
Thirty trades in 90 days puts Warner in the active tier of Senate traders. Not the most aggressive filer on the Hill, but not a set-it-and-forget-it index fund guy either. The April 13 batch alone accounts for 11 disclosed positions: selling out of growth ETFs, rotating into individual names across banking, technology, and mortgage finance.
Rocket Companies is a mortgage lender. Blackstone is private equity, deeply involved in real estate credit. Wells Fargo is Wells Fargo. All three purchased on the same day. The Senate Banking Committee has jurisdiction over all three sectors. Warner chairs no subcommittee in name but sits on Financial Institutions and Consumer Protection, which covers bank supervision directly.
The institutional deadpan version: members of the Banking Committee are legally permitted to hold bank stocks while overseeing bank regulation. This has always been the rule. The rule has always been the point.
The Microsoft purchase also cleared April 13. Warner sits on no technology-specific committee by that exact name, but the Intelligence Committee has extensive equities in technology policy, cloud contracts, and surveillance infrastructure. Microsoft is one of the largest government cloud vendors in the world. The overlap flag in the data is listed as "Technology." Draw your own radius.
What He's Saying vs. What He's Filing
Warner's public argument this week is that Trump's tariff policy is economically reckless. That's a view held by a lot of economists, a lot of market participants, and, per the April 13 filing, apparently not enough to keep him from buying into Wells Fargo and Blackstone during the same stretch of market volatility those tariffs were generating.
That's not hypocrisy exactly. It might just be a senator who thinks the policy is bad and also thinks the dip is temporary. Those two things can coexist. They do coexist, constantly, on the Hill.
What the filings don't show is any trade-to-vote timing overlap that Blind Trust's system flagged. The vote_trade_overlaps array is empty. The committee overlap trades exist, but their alpha is mixed enough that no directional inference survives the full sample. The mean is -3.8%. You don't optimize for -3.8%.
What the filings do show is a senator who talks about the economy in public and manages a fairly active personal portfolio in private, in sectors he oversees, at a pace most of his constituents couldn't replicate from their own committee rooms.
Warner's full disclosure record is on Blind Trust. The CNN quote is on the record. The trades are disclosed. Everything here is public.
It's legal. That's the part that should bother you.